RadNet (RDNT) M&A announcement summary

Deal rationale and strategic fit

• Combines outpatient imaging and DeepHealth AI with ONRAD’s teleradiology and hospital staffing, extending radiology services across the diagnostic imaging continuum.

• Addresses rising imaging demand and constrained radiologist capacity through AI-enabled workflows, teleradiology and staffing.

• ONRAD will anchor a third reportable operating segment, Radiology Professional Services.

Financial terms and conditions

• Initial consideration: $350 million cash and 5 million common shares, subject to customary adjustments.

• Earnout of up to $210 million based on 2027 Adjusted EBITDA, payable in cash and/or stock at the buyer’s election.

• First-year post-close contribution expected at $190 million–$200 million in revenue and $60 million–$65 million in Adjusted EBITDA; estimate reflects ONRAD’s standalone budget.

• Projected first-year Adjusted EBITDA margin exceeds 30%, with free cash flow conversion of 95%+ and low capital needs.

Synergies and expected cost savings

• Cross-marketing digital health products to ONRAD’s 225 hospital customers and pursuing outpatient joint ventures could support organic growth.

• AI-enabled tools include automated case assignment and prioritization, findings visualization, draft report generation and simplified radiologist review.

• Combined capabilities are expected to improve efficiency, patient care and costs across diagnostic imaging settings.